Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market
Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art
The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home
Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home
Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal
CEOs from diverse sectors on what's in store for 2017
After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?
Looking for cash bargains? Here is a first cut list
The Sun Pharma founder is a man of few words and the perfect dose of calm and strength
India's most reticent billionaire is betting his money on the alternative energy space and here's why
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
Drug majors are shifting clinical trials out of India as lawmakers turn on the heat
He has tirelessly fought against a monopoly in life-saving drugs. Fighting alone has failed to dissuade him
It took Reebok India five years to wake up to financial irregularities of nearly ₹900 crore. What happens now?